Advanced medtech is shifting the balance in wound management

Global markets for sales of wound management products are projected to evolve through 2020, with advanced wound management technologies progressively tapping into previously underserved (or unserved) clinical need or displacing caseload treated via traditional wound management products. The result is a shift in the balance of traditional/advanced product revenue shares of the total market, as illustrated below:

The need for medtech products to provide reduced risk of infection, faster healing, fewer complications and lowered cost (especially for chronic wounds) is resulting in growth for advanced products, despite their upfront higher costs, at the expense of traditional wound dressings and bandages.